Sleep Aids Market Size is Expected to Reach US$ 79,851 million by 2022 with Merck & Co., Sanofi, Pfizer Inc., SleepMed, Compumedics, GlaxoSmithKline plc.

Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. Sleep aids help to improve the quality of sleep by reducing the time required to fall asleep and increasing the duration of quality sleep. The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023.

Get PDF sample copy:

Companies Covered in this Report are:

Koninklijke Philips N.V.
Merck & Co.
DeVilbiss Healthcare LLC.
Pfizer Inc.
SleepMed Inc.
Cadwell Laboratories Inc.
Compumedics Limited
Natus Medical Incorporated
GlaxoSmithKline plc.

The global sleep aids market is segmented based on product, sleep disorder, and geography. Based on product, it is categorized into mattress & pillows, sleep laboratories, medications, and sleep apnea devices. The medications segment is further divided into prescription-based drugs, over-the-counter (OTC) drugs, and herbal drugs. Based on sleep disorder, it is classified into insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and other sleep disorder. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle. The surge in disposable income; increase in awareness about sleep disorders; stressful work issues; enhanced intake of caffeine, tobacco, and alcohol; and technological advancements are expected to boost the sleep aids market growth. However, adverse effects of sleep aids medication in patient with sleep disorders, such as dizziness, diarrhea, constipation, daytime drowsiness; and expiration on sleep drugs patents are expected to hamper the market growth.

This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
Market estimations provided are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product, sleep disorder, and geography.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

To Purchase This report details at:

Sleep Aids Market Key Segments

Mattresses & Pillows
Sleep Laboratories
Prescription-based drugs
OTC drugs
Herbal drugs
Sleep Apnea Devices

Sleep Apnea
Restless Legs Syndrome
Sleep Walking
Other Sleep Disorders

North America
Rest of Europe
Rest of Asia-Pacific
Republic of South Africa
Saudi Arabia
Rest of LAMEA

The other players of the sleep aids market include (companies not profiled in the report):
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
CareFusion Corporation
Tempur-Pedic Management Inc.
Serta International
Drive Medical Ltd.

About Premium Market Insights:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

Contact Us:
Name: Sameer Joshi
Organization: Premium Market Insights
Email: [email protected]
Phone: +1-646-491-9876

Posted by on Monday September 16 2019, 7:01 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Business Services, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in